Send us Feedback

Daiichi Sankyo Company (4568-TO)
Analysis
SUMMARY
BULLS
BEARS
Data
STOCK CHART
QUOTE AND NEWS
New Drugs Will Propel Growth, Say Astellas, Daiichi Sankyo
Wall Street Journal  May 14  Comment 
Japan's No. 2 and No. 3 drug makers, battling to offset revenue lost from patent expirations, predicted growth in the current fiscal year with solid sales of new drugs.
New Drugs Will Propel Growth, Say Astellas, Daiichi Sankyo
Wall Street Journal  May 13  Comment 
Japan's No. 2 and No. 3 drug makers, battling to offset revenue lost from patent expirations, predicted growth in the current fiscal year with solid sales of new drugs.
Daiichi Sankyo ditches cancer drug program from ArQule
FierceBiotech  Apr 1  Comment 
After a pair of trial setbacks with a separate program from ArQule, Japan-based drugmaker Daiichi Sankyo has decided to jettison an alliance with the Woburn, MA-based drug developer on an early-stage compound known as ARQ 092. ArQule ($ARQL)...
Daiichi Sankyo Develops Nucleic Acid Treatment for Duchenne Muscular Dystrophy
JCN Network  Feb 16  Comment 
Daiichi Sankyo will collaborate with a new company, Orphan Disease Treatment Institute, in the development of a treatment for Duchenne muscular dystrophy (DMD) with the active ingredient ENA oligonucleotide, a modified nucleic acid made using...




more ▼WIKI ANALYSIS
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800.
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


You may also be interested in articles related to Daiichi Sankyo Company (4568-TO):
 
Retrieved from "http://www.wikinvest.com/stock/Daiichi_Sankyo_Company_(4568-TO)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki